
The MIDAS trial: MRD guided therapy for newly-diagnosed multiple myeloma
At EHA 2025, early results of the MRD-driven consolidation phase of the trial were presented. In this video, Prof Claudio Cerchione explains why MRD-driven treatment strategies like the one evaluated